Brief

On December 20, 2024, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding "Prevention of chemical submission: ANSM takes new measures to reduce the risk of drug misuse". The agency reported a significant increase in reports and a part of psychoactive medications involved at 56.7%, prompting measures with laboratories that commercialize potentially diverted medications.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies